KRTL Holding Group, Inc. (KRTL)

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Year Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Biotechnology Research and Development	2.67M
Biotechnology Research and Development Growth	8172.74%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Year Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
United States	2.67M
United States Growth	8172.74%

Data Source: Finnhub Last updated: Dec 31, 2004

Financial data is provided by Finnhub and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 6, 2026

Data Sources Report a data error